Abstract
The structures of ketanserin (1) and spiperone (2) were examined in detail to determine the role of various substituent groups on 5-HT2A receptor affinity and selectivity. It was found that the presence of the quinazoline ring of ketanserin detracts from selectivity and that various ring-opened analogs displayed ketanserin-like affinity and up to 30-fold enhanced selectivity. The triazaspirodecanone portion of spiperone is a major determinant of its 5-HT2A affinity and selectivity. The conformational rigidity imposed by the ring, as well as the nature of the N1-substituent, are important factors in controlling binding at 5-HT2A, 5-HT2C, 5-HT1A, and dopamine D2 receptors. Replacement of the N1-phenyl ring of spiperone with a methyl group (KML-010 48) resulted in a compound that binds at 5-HT2A receptors with slightly lower affinity than spiperone, but that lacked affinity (Ki > 10,000 nM) for 5-HT2C and 5-HT1A receptors and binds with 400-fold reduced affinity at D2 receptors.
Keywords: Ketanserin and Spiperone, Serotonin 5-HT2A, KETANSERIN ANALOGS, Quinazoline-Abbreviated Analogs, Benzoylpiperidine
Current Topics in Medicinal Chemistry
Title: Ketanserin and Spiperone as Templates for Novel Serotonin 5-HT2A Antagonists
Volume: 2 Issue: 6
Author(s): Richard A. Glennon, Kamel Metwally, Malgorzata Dukat, Abd M. Ismaiel, Joseph De. Los Angeles, Jeffery Herndon, Milt Teitler and Nantaka Khorana
Affiliation:
Keywords: Ketanserin and Spiperone, Serotonin 5-HT2A, KETANSERIN ANALOGS, Quinazoline-Abbreviated Analogs, Benzoylpiperidine
Abstract: The structures of ketanserin (1) and spiperone (2) were examined in detail to determine the role of various substituent groups on 5-HT2A receptor affinity and selectivity. It was found that the presence of the quinazoline ring of ketanserin detracts from selectivity and that various ring-opened analogs displayed ketanserin-like affinity and up to 30-fold enhanced selectivity. The triazaspirodecanone portion of spiperone is a major determinant of its 5-HT2A affinity and selectivity. The conformational rigidity imposed by the ring, as well as the nature of the N1-substituent, are important factors in controlling binding at 5-HT2A, 5-HT2C, 5-HT1A, and dopamine D2 receptors. Replacement of the N1-phenyl ring of spiperone with a methyl group (KML-010 48) resulted in a compound that binds at 5-HT2A receptors with slightly lower affinity than spiperone, but that lacked affinity (Ki > 10,000 nM) for 5-HT2C and 5-HT1A receptors and binds with 400-fold reduced affinity at D2 receptors.
Export Options
About this article
Cite this article as:
Glennon A. Richard, Metwally Kamel, Dukat Malgorzata, Ismaiel M. Abd, Los Angeles De. Joseph, Herndon Jeffery, Teitler Milt and Khorana Nantaka, Ketanserin and Spiperone as Templates for Novel Serotonin 5-HT2A Antagonists, Current Topics in Medicinal Chemistry 2002; 2 (6) . https://dx.doi.org/10.2174/1568026023393787
DOI https://dx.doi.org/10.2174/1568026023393787 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements